European Commission Launches Investigation into Health Risks of Bute
The European Commission has asked the European Food Safety Authority and European Medicines Agency to conduct an investigation into phenylbutazone’s effects on human health. The medication has been reported to be toxic to bone marrow and may be associated with blood disorders and cancer.
The request came as the horsemeat crisis continues to grow in Europe.
The Commission adopted testing protocols for phenylbutazone in correctly-labeled samples of horsemeat sold in Europe. Anti-slaughter advocates claim that bute regularly enters the human food chain, while slaughterhouse officials say they regularly conduct testing and do not allow horsemeat containing the medication to be sold for human consumption.
Results of the study are expected April 15.
Read more at the Daily Racing Form